Abstract：Ischemic white matter lesions is one of the most common cerebral white matter diseases. Many etiological factors could lead to ischemic white matter lesions. Early identification, definition of risk factors, and intervention of the disease could help to improve the patient′s quality of life in the future. This article reviews the studies on the risk factors, pathophysiological mechanisms and clinical manifestations of ischemic white matter lesions in middle and senile patients in the last decade.
[1] 黄世敬，王永炎.培元通滞治疗缺血性脑白质病思路探讨[J].中国中医基础医学杂志，2012，18（2）：173-174， 182.
[2] Stefanova E，Pavlovic A，Jovanovic Z，et al. Vascular risk factors in Alzheimer's disease - preliminary report [J]. J Neurol Sci，2012，322（1/2）：166-169.
[3] Pantoni L. Leukoaraiosis：from an ancient term to an actual marker of poor prognosis [J]. Stroke，2008，39（5）：1409-1413.
[4] 乔保俊，胡良晨.卒中危险因素的研究与预防[J].济宁医学院学报，2017，40（5）：382-388.
[5] Takahashi R，Ishii K，Kakigi T，et al. Gender and age differences in normal adult human brain：Voxel‐based morphometric study [J]. Hum Brain Mapp，2011，32（7）：1050-1058.
[6] 睢海龙，黄维星，师海玲.脑白质疏松相关危险因素研究进展[J].包头医学院学报，2015，31（8）：156-158.
[7] Webb AJ，Simoni M，Mazzucco S，et al. Increased cerebral arterial pulsatility in patients with leukoaraiosis：arterial stiffness enhances transmission of aortic pulsatility [J]. Stroke，2012，43（10）：2631-2636.
[8] Sijens PE，Oudkerk M，de Leeuw FE，et al. 1H chemical shift imaging of the human brain at age 60-90 years reveals metabolic differences between women and men [J]. Magnetic Resonance in Medicine，1999，42（1）：24-31.
[9] 张帅，林志坚，吴军，等.缺血性脑白质疏松症危险因素的临床研究[J].中风与神经疾病杂志，2010，27（1）：28-31.
[10] Seo SK，Jung I，Lee SM，et al. Relationship between le-ukoaraiosis and menopause in healthy middle-aged women [J]. Fertil Steril，2013，100（2）：500-504.
[11] Stavitsky K，Du Y，Seichepine D，et al. White Matter Hyperintensity and Cognitive Functioning in the Racial and Ethnic Minority Cohort of the Framingham Heart Study [J]. Neuroepidemiology，2010，35（2）：117-122.
[12] Joutel A，Corpechot C，Ducros A，et al. Notch3 mutations in CADASIL，a hereditary adult-onset condition causing stroke and dementia [J]. Nature，1996，383（6602）：707-710.
[13] Knopman DS，Roberts R. Vascular risk factors：imaging and neuropathologic correlates [J]. J Alzheimers Dis，2010，20（3）：699-709.
[14] Dufouil C，Chalmers J，Coskun O，et al. Effects of Blood Pressure Lowering on Cerebral White Matter Hyperintensities in Patients With Stroke The PROGRESS（Perindopril Protection Against Recurrent Stroke Study）Magnetic Resonance Imaging Substudy [J]. Circulation，2005，112（11）：1644-1650.
[15] Godin O，Tzourio C，Maillard P，et al. Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes：the Three-City（3C）-Dijon Magnetic Resonance Imaging Study [J]. Circulation，2011，123（3）：266-273.
[16] Reshef S，Fried L，Beauchamp N，et al. Diastolic Blood Pressure Levels and Ischemic Stroke Incidence in Older Adults With White Matter Lesions [J]. J Gerontol A Biol Sci Med Sci，2011，66A（1）：74.
[17] Park K，Yasuda N，Toyonaga S，et al. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects [J]. Neurology，2007，69（10）：974-978.
[18] Del Bene A，Ciolli L，Borgheresi L，et al. Is type 2 diabetes related to leukoaraiosis? an updated review [J]. Acta Neurol Scand，2015，132（3）：147-155.
[19] Poggesi A，Gouw A，van der Flier W，et al. Neurological abnormalities predict disability：the LADIS（Leukoaraiosis And DISability）study [J]. J Neurol，2014，261（6）：1160-1169.
[20] Kim BJ，Lee SH，Kang BS，et al. Diabetes increases large artery diseases，but not small artery diseases in the brain [J]. J Neurol，2008，255（8）：1176-1181.
[21] Feng C，Bai X，Xu Y，et al. Hyperhomocysteinemia Associates with Small Vessel Disease More Closely Than Large Vessel Disease [J]. Int J Med Sci，2013，10（4）：408-412.
[22] Hassan A，Hunt BJ，O'Sullivan M，et al. Homocysteine is a risk factor for cerebral small vessel disease，acting via endothelial dysfunction [J]. Brain，2004，127（Pt 1）：212-219.
[23] Doshi SN，Mcdowell IF，Moat SJ，et al. Folate improves endothelial function in coronary artery disease：an effect mediated by reduction of intracellular superoxide? [J]. Arterioscler Thromb Vasc Biol，2001，21（7）：1196-1202.
[24] Sampat R，Young S，Rosen A，et al. Potential mechanisms for low uric acid in Parkinson disease [J]. J Neural Transm（Vienna），2016，123（4）：365-370.
[25] Liu X，Liu M，Chen M，et al. Serum Uric Acid Is Neuroprotective in Chinese Patients with Acute Ischemic Stroke Treated with Intravenous Recombinant Tissue Plasminogen Activator [J]. J Stroke Cerebrovasc Dis，2015，24（5）：1080-1086.
[26] Chuang YM，Huang KL，Chang YJ，et al. Associations between Circle of Willis Morphology and White Matter Lesion Load in Subjects with Carotid Artery Stenosis [J]. European Neurology，2011，66（3）：136-144.
[27] Kim J，Song TJ，Song D，et al. Serum alkaline phosphatase and phosphate in cerebral atherosclerosis and functional outcomes after cerebral infarction [J]. Stroke，2013，44（12）：3547-3549.
[28] Grubb A1，Bj?觟rk J，Nyman U，et al. Cystatin C，a marker for successful aging and glomerular filtration rate，is not influenced by inflammation [J]. Scand J Clin Lab Invest，2011，71（2）：145-149.
[29] 吕雅静.高龄缺血性脑白质病变与血清胱抑素C的关系[D].北京：中国人民解放军医学院，2017.
[30] 张晖，柴瑞新，窦瑞芳，等.DTI研究脑白质疏松症对皮质脊髓束的影响[J].中国医药科学，2016，6（16）：17-20，24.
[31] Lafarge JC，Naour N，Clément K，et al. Cathepsins and cystatin C in atherosclerosis and obesity [J]. Biochimie，2010，92（11）：1580-1586.
2018, Vol. 15 
京公网安备 11010502046598号